Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Defiance Next Gen Altered Experience ETF (NY: PSY )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Aug 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.700 (25)
Ask (Size) 6.030 (1)
Prev. Close 5.900
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 8,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
With EFT Defiance Psychedelics Fund Closing, Let's Take A Look At Market Movement
The fund owning the Defiance Next Gen Altered Experience ETF (NYSEARCA: PSY) and Defiance Next Gen SPAC Derived ETF funds, ETF Series Solutions recently decided to close and liquidate each fund. 
Via Benzinga
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous opportunity for inv... 
Via Benzinga

Performance

More News

Read More
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Via Benzinga
The New Defiance "Psychedelic" ETF Is Not What It Is Purported To Be
Via Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Via Benzinga
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
Via Talk Markets
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
Via Benzinga
Which Psychedelic Stock ETF Is Right For You?
Via Talk Markets
Want Quick Exposure To The Psychedelics Sector? Check Out This New Active ETF
Via Benzinga
Psychedelic Drug Industry Report Card For 2021
Via Talk Markets
Which Psychedelic Drug Has The Most Commercial Potential?
Via Talk Markets
First Look ETF: Analyzing New ETFs that use Machine Learning and Tackle Mental Health
Via Talk Markets
The 6 Leading Psychedelic Stocks In Drug R&D
Via Talk Markets
A New Psychedelics Stocks ETF Just Launched: Here's Why It's Important
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Psyched: First Psychedelics ETF Comes To The US, Bills Move Forward In Texas, California and New York
Via Benzinga
Why Seelos Therapeutics Stock Is Jumping Today
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.